{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "27729375", "DateCompleted": {"Year": "2017", "Month": "09", "Day": "06"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "03"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2016", "Month": "10", "Day": "11"}], "ELocationID": ["10.1093/carcin/bgw106"], "Journal": {"ISSN": "1460-2180", "JournalIssue": {"Volume": "38", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Jan"}}, "Title": "Carcinogenesis", "ISOAbbreviation": "Carcinogenesis"}, "ArticleTitle": "Role of p53 in silibinin-mediated inhibition of ultraviolet B radiation-induced DNA damage, inflammation and skin carcinogenesis.", "Pagination": {"StartPage": "40", "EndPage": "50", "MedlinePgn": "40-50"}, "Abstract": {"AbstractText": ["Non-melanoma skin cancers (NMSC) are a growing problem given that solar ultraviolet B (UVB) radiation exposure is increasing most likely due to depletion of the atmospheric ozone layer and lack of adequate sun protection. Better preventive methods are urgently required to reduce UV-caused photodamage and NMSC incidence. Earlier, we have reported that silibinin treatment activates p53 and reduces photodamage and NMSC, both in vitro and in vivo; but whether silibinin exerts its protective effects primarily through p53 remains unknown. To address this question, we generated p53 heterozygous (p53<sup>+/-</sup>) and p53 knockout (p53<sup>-/-</sup>) mice on SKH-1 hairless mouse background, and assessed silibinin efficacy in both short- and long-term UVB exposure experiments. In the chronic UVB-exposed skin tumorigenesis study, compared to p53<sup>+/+</sup> mice, p53<sup>+/-</sup> mice developed skin tumors earlier and had higher tumor number, multiplicity and volume. Silibinin topical treatment significantly reduced the tumor number, multiplicity and volume in p53<sup>+/+</sup> mice but silibinin' protective efficacy was significantly compromised in p53<sup>+/-</sup> mice. Additionally, silibinin treatment failed to inhibit precursor skin cancer lesions in p53<sup>-/-</sup> mice but improved the survival of the mice. In short-term studies, silibinin application accelerated the removal of UVB-induced DNA damage in p53<sup>+/+</sup> mice while its efficacy was partially compromised in p53<sup>-/-</sup> mice. Interestingly, silibinin treatment also inhibited the UVB-induced inflammatory markers in skin tissue. These results further confirmed that absence of the p53 allele predisposes mice to photodamage and photocarcinogenesis, and established that silibinin mediates its protection against UVB-induced photodamage, inflammation and photocarcinogenesis partly through p53 activation."], "CopyrightInformation": "\u00a9 The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences."}], "LastName": "Rigby", "ForeName": "Cynthia M", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences."}, {"Identifier": [], "Affiliation": "Present address: Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA."}], "LastName": "Roy", "ForeName": "Srirupa", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences."}, {"Identifier": [], "Affiliation": "University of Colorado Cancer Center and."}], "LastName": "Deep", "ForeName": "Gagan", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences."}], "LastName": "Guillermo-Lagae", "ForeName": "Ruth", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences."}], "LastName": "Jain", "ForeName": "Anil K", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences."}], "LastName": "Dhar", "ForeName": "Deepanshi", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, University of Colorado Denver, Aurora, CO 80045, USA."}], "LastName": "Orlicky", "ForeName": "David J", "Initials": "DJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences."}, {"Identifier": [], "Affiliation": "University of Colorado Cancer Center and."}], "LastName": "Agarwal", "ForeName": "Chapla", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, rajesh.agarwal@ucdenver.edu."}, {"Identifier": [], "Affiliation": "University of Colorado Cancer Center and."}], "LastName": "Agarwal", "ForeName": "Rajesh", "Initials": "R"}], "GrantList": [{"GrantID": "R01 CA140368", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Carcinogenesis", "NlmUniqueID": "8008055", "ISSNLinking": "0143-3334"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Silymarin"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Suppressor Protein p53"}, {"RegistryNumber": "4RKY41TBTF", "NameOfSubstance": "Silybin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug effects", "pathology", "radiation effects"], "DescriptorName": "Cell Transformation, Neoplastic"}, {"QualifierName": ["drug effects", "radiation effects"], "DescriptorName": "DNA Damage"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["etiology", "pathology", "prevention & control"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Hairless"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Knockout"}, {"QualifierName": [], "DescriptorName": "Silybin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Silymarin"}, {"QualifierName": ["etiology", "pathology", "prevention & control"], "DescriptorName": "Skin Neoplasms"}, {"QualifierName": ["physiology"], "DescriptorName": "Tumor Suppressor Protein p53"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ultraviolet Rays"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gu M., et al. (2005) Dietary feeding of silibinin prevents early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Cancer Epidemiol. Biomarkers Prev., 14, 1344\u20131349.", "ArticleIdList": ["15894701"]}, {"Citation": "Singh R.P., et al. (2002) Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis, 23, 499\u2013510.", "ArticleIdList": ["11895866"]}, {"Citation": "Gu M., et al. (2007) Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res., 67, 3483\u20133491.", "ArticleIdList": ["17409458"]}, {"Citation": "Mallikarjuna G., et al. (2004) Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res., 64, 6349\u20136356.", "ArticleIdList": ["15342425"]}, {"Citation": "Khan A.Q., et al. (2014) Silibinin inhibits tumor promotional triggers and tumorigenesis against chemically induced two-stage skin carcinogenesis in Swiss albino mice: possible role of oxidative stress and inflammation. Nutr. Cancer, 66, 249\u2013258.", "ArticleIdList": ["24364787"]}, {"Citation": "Ramasamy K., et al. (2008) Multitargeted therapy of cancer by silymarin. Cancer Lett., 269, 352\u2013362.", "ArticleIdList": ["PMC2612997", "18472213"]}, {"Citation": "Roy S., et al. (2012) Silibinin prevents ultraviolet B radiation-induced epidermal damages in JB6 cells and mouse skin in a p53-GADD45\u03b1-dependent manner. Carcinogenesis, 33, 629\u2013636.", "ArticleIdList": ["PMC3384068", "22166495"]}, {"Citation": "Dhanalakshmi S., et al. (2004) Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis. Carcinogenesis, 25, 1459\u20131465.", "ArticleIdList": ["15033902"]}, {"Citation": "de Gruijl F.R., et al. (2008) Early events in UV carcinogenesis\u2013DNA damage, target cells and mutant p53 foci. Photochem. Photobiol., 84, 382\u2013387.", "ArticleIdList": ["18221455"]}, {"Citation": "Ikehata H., et al. (2010) Influences of p53 deficiency on the apoptotic response, DNA damage removal and mutagenesis in UVB-exposed mouse skin. Mutagenesis, 25, 397\u2013405.", "ArticleIdList": ["20462948"]}, {"Citation": "Amundson S.A., et al. (2002) A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol. Ther., 1, 145\u2013149.", "ArticleIdList": ["12170774"]}, {"Citation": "Adimoolam S., et al. (2003) p53 and regulation of DNA damage recognition during nucleotide excision repair. DNA Repair (Amst)., 2, 947\u2013954.", "ArticleIdList": ["12967652"]}, {"Citation": "Guillermo-Lagae R., et al. (2015) Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts. Oncotarget, 6, 39594\u201339606.", "ArticleIdList": ["PMC4741848", "26447614"]}, {"Citation": "Freed-Pastor W.A., et al. (2012) Mutant p53: one name, many proteins. Genes Dev., 26, 1268\u20131286.", "ArticleIdList": ["PMC3387655", "22713868"]}, {"Citation": "Benjamin C.L., et al. (2007) p53 and the pathogenesis of skin cancer. Toxicol. Appl. Pharmacol., 224, 241\u2013248.", "ArticleIdList": ["PMC2080850", "17270229"]}, {"Citation": "Benavides F., et al. (2009) The hairless mouse in skin research. J. Dermatol. Sci., 53, 10\u201318.", "ArticleIdList": ["PMC2646590", "18938063"]}, {"Citation": "Ouhtit A., et al. (2000) Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis. Am. J. Pathol., 157, 1975\u20131981.", "ArticleIdList": ["PMC1885778", "11106570"]}, {"Citation": "Maru G.B., et al. (2014) The role of inflammation in skin cancer. Adv. Exp. Med. Biol., 816, 437\u2013469.", "ArticleIdList": ["24818733"]}, {"Citation": "Kim Y., et al. (2014) Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes Dis., 1, 188\u2013198.", "ArticleIdList": ["PMC4307792", "25642450"]}, {"Citation": "Ryser S., et al. (2014) UVB-induced skin inflammation and cutaneous tissue injury is dependent on the MHC class I-like protein, CD1d. J. Invest. Dermatol., 134, 192\u2013202.", "ArticleIdList": ["PMC3898102", "23867896"]}, {"Citation": "Clydesdale G.J., et al. (2001) Ultraviolet light induced injury: immunological and inflammatory effects. Immunol. Cell Biol., 79, 547\u2013568.", "ArticleIdList": ["11903614"]}, {"Citation": "Budunova I.V., et al. (1999) Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Oncogene, 18, 7423\u20137431.", "ArticleIdList": ["10602501"]}, {"Citation": "Rundhaug J.E., et al. (2007) A role for cyclooxygenase-2 in ultraviolet light-induced skin carcinogenesis. Mol. Carcinog., 46, 692\u2013698.", "ArticleIdList": ["17443745"]}, {"Citation": "Moore R.J., et al. (1999) Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat. Med., 5, 828\u2013831.", "ArticleIdList": ["10395330"]}, {"Citation": "Potter G.B., et al. (2001) The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev., 15, 2687\u20132701.", "ArticleIdList": ["PMC312820", "11641275"]}, {"Citation": "Narayanapillai S., et al. (2014) Silibinin inhibits ultraviolet B radiation-induced DNA-damage and apoptosis by enhancing interleukin-12 expression in JB6 cells and SKH-1 hairless mouse skin. Mol. Carcinog., 53, 471\u2013479.", "ArticleIdList": ["PMC3883799", "23359305"]}, {"Citation": "van Kranen H.J., et al. (2005) Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice. Mutat. Res., 571, 81\u201390.", "ArticleIdList": ["15748640"]}, {"Citation": "Sun Y. (2006) p53 and its downstream proteins as molecular targets of cancer. Mol. Carcinog., 45, 409\u2013415.", "ArticleIdList": ["16652354"]}, {"Citation": "Mancebo S.E., et al. (2014) Sunscreens: a review of health benefits, regulations, and controversies. Dermatol. Clin., 32, 427\u201338, x.", "ArticleIdList": ["24891063"]}, {"Citation": "Gu M., et al. (2005) Dietary feeding of silibinin prevents early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Cancer Epidemiol Biomarkers Prev, 14, 1344\u20139.", "ArticleIdList": ["15894701"]}, {"Citation": "Gu M., et al. (2006) Differential effect of silibinin on E2F transcription factors and associated biological events in chronically UVB-exposed skin versus tumors in SKH-1 hairless mice. Mol. Cancer Ther., 5, 2121\u20132129.", "ArticleIdList": ["16928834"]}, {"Citation": "Melnikova V.O., et al. (2005) Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development. Oncogene, 24, 7055\u20137063.", "ArticleIdList": ["16007135"]}, {"Citation": "Molavi O., et al. (2015) Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma. Leuk Lymphoma, 1\u20139.", "ArticleIdList": ["26133723"]}, {"Citation": "Kumar J., et al. (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer\u2019s model. CNS Neurol. Disord. Drug Targets, 14, 295\u2013302.", "ArticleIdList": ["25613505"]}, {"Citation": "Wellington K., et al. (2001) Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs, 15, 465\u2013489.", "ArticleIdList": ["11520257"]}, {"Citation": "Adimoolam S., et al. (2002) p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl. Acad. Sci. USA, 99, 12985\u201312990.", "ArticleIdList": ["PMC130573", "12242345"]}, {"Citation": "Marteijn J.A., et al. (2014) Understanding nucleotide excision repair and its roles in cancer and ageing. Nat. Rev. Mol. Cell Biol., 15, 465\u2013481.", "ArticleIdList": ["24954209"]}, {"Citation": "Smith M.L., et al. (2002) p53 regulation of DNA excision repair pathways. Mutagenesis, 17, 149\u2013156.", "ArticleIdList": ["11880544"]}, {"Citation": "Zhan Q., et al. (1996) Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation. DNA Cell Biol., 15, 805\u2013815.", "ArticleIdList": ["8892753"]}, {"Citation": "Lawrence T. (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol., 1, a001651.", "ArticleIdList": ["PMC2882124", "20457564"]}, {"Citation": "Yamamoto Y., et al. (2004) IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem. Sci., 29, 72\u201379.", "ArticleIdList": ["15102433"]}, {"Citation": "Dolcet X., et al. (2005) NF-kB in development and progression of human cancer. Virchows Arch., 446, 475\u2013482.", "ArticleIdList": ["15856292"]}, {"Citation": "Syed D.N., et al. (2012) Differential activation of signaling pathways by UVA and UVB radiation in normal human epidermal keratinocytes. Photochem. Photobiol., 88, 1184\u20131190.", "ArticleIdList": ["PMC3445260", "22335604"]}, {"Citation": "Philip M., et al. (2004) Inflammation as a tumor promoter in cancer induction. Semin. Cancer Biol., 14, 433\u2013439.", "ArticleIdList": ["15489136"]}, {"Citation": "Chang E.J., et al. (2011) Ultraviolet B radiation activates NF-kappaB and induces iNOS expression in HR-1 hairless mouse skin: role of IkappaB kinase-beta. Mol. Carcinog., 50, 310\u2013317.", "ArticleIdList": ["21465579"]}, {"Citation": "Benoit V., et al. (2006) Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB. Oncogene, 25, 5708\u20135718.", "ArticleIdList": ["16682957"]}, {"Citation": "Buckman S.Y., et al. (1998) COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis, 19, 723\u2013729.", "ArticleIdList": ["9635856"]}, {"Citation": "Athar M., et al. (2001) Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study. Biochem. Biophys. Res. Commun., 280, 1042\u20131047.", "ArticleIdList": ["11162632"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "4", "Day": "29"}, {"Year": "2016", "Month": "10", "Day": "10"}, {"Year": "2016", "Month": "9", "Day": "2"}, {"Year": "2016", "Month": "11", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "10", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27729375", "PMC5219048", "10.1093/carcin/bgw106", "bgw106"]}}], "PubmedBookArticle": []}